Ecotin: A serine protease inhibitor with two distinct and interacting binding sites

Journal of Molecular Biology

Volumn 279, Issue 4, 1998, Pages 945-957

  Yang, Steve Q ^a   Wang, Cheng I ^a,b   Gillmor, Sarah A ^a   Fletterick, Robert J ^a   Craik, Charles S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neurex Corporation   (United States)

Author keywords

Dimeric inhibitor; Ecotin; Protease inhibitor; Specificity; uPA

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; ASPARTIC ACID; CHYMOTRYPSIN; DIMER; GLYCINE; LEUCINE; LYSINE; SERINE PROTEINASE INHIBITOR; TRYPSIN; TRYPTOPHAN; TYROSINE; UROKINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; SITE DIRECTED MUTAGENESIS;

ANIMALIA; BOVINAE; TRIXIS;

EID: 0032546757     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.1748     Document Type: Article

References (30)

1. Barrett, A. J. (1981). Alpha 2-macroglobulin. Methods Enzymol. 80 Pt C, 737-754.
2. Bode, W. & Huber, R. (1992). Natural protein proteinase inhibitors and their interaction with proteinase. Eur. J. Biochem. 204 (2), 433-451.
3. Chung, C. H., Ives, H. E., Almeda, S. & Goldberg, A. L. (1983). Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases. J. Biol. Chem, 258(18), 11032-11038.
4. Dayringer, H. E., Tramontano, A., Sprang, S. R. & Fletterick, R. J. (1986). InsightII. Mol. Graph. 4, 82-87.
5. Engh, R. A., Huber, R., Bode, W. & Schulze, A. J. (1995). Divining the serpin inhibition mechanism: a suicide substrate 'spring'? Trends Biotechnol. 13(12), 503-510.
6. Higaki, J. N., Evnin, L. B. & Craik, C. S. (1989). Introduction of a cysteine protease active site into trypsin. Biochemistry, 28(24), 9256-9263.
7. Kossiakoff, A. A., Hynes, T. & de Vos, A. (1993). Molecular recognition in biological systems: from activation to inhibition. Biochem. Soc. Trans. 21(Pt 3), 614-618.
8. Kunkel, T. A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA, 82(2), 488-492.
9. Laskowski, M. J. & Kato, I. (1980). Protein inhibitions of proteinases. Annu. Rev. Biochem. 49(593), 593-626.
10. Lee, B. & Richards, F. M. (1971). The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55(3), 379-400.
11. Lu, W., Apostol, I., Qasim, M. A., Warne, N., Wynn, R., Zhang, W. L., Anderson, S., Chiang, Y. W., Ogin, E., Rothberg, I., Ryan, K. & Laskowski, M., Jr (1997). Binding of amino acid side-chains to S1 cavities of serine proteinases. J. Mol. Biol. 266(2), 441-461.
12. McGrath, M. E., Erpel, Y., Browner, M. F. & Fletterick, R. J. (1991a). Expression of the protease inhibitor ecotin and its co-crystallization with trypsin. J. Mol. Biol. 222(2), 139-142.
13. McGrath, M. E., Hines, W. M., Sakanari, J. A., Fletterick, R. J. & Craik, C. S. (1991b). The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli. J. Biol. Chem. 266(10), 6620-6625.
14. McGrath, M. E., Erpel, T., Bystroff, C. & Fletterick, R. J. (1994). Macromolecular chelation as an improved mechanism of protease inhibition: structure of the ecotin-trypsin complex. EMBO J. 13(7), 1502-1507.
15. Morrison, J. F. (1969). Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. Biochim. Biophys. Acta, 185(2), 269-286.
16. Pal, G., Sprengel, G., Patthy, A. & Graf, L. (1994). Alteration of the specificity of ecotin, an E. coli serine proteinase inhibitor, by site directed mutagenesis. FEBS Letters, 342(1), 57-60.
17. Pal, G., Szilagyi, L. & Graf, L. (1996). Stable monomeric form of an originally dimeric serine proteinase inhibitor, ecotin, was constructed via site directed mutagenesis. FEBS Letters, 385(3), 165-170.
18. Qasim, M. A., Ganz, P. J., Saunders, C. W., Bateman, K. S., James, M. N. & Laskowski, M., Jr (1997). Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. Biochemistry, 36(7), 1598-1607.
19. Rydel, T. J., Ravichandran, K. G., Tulinsky, A., Bode, W., Huber, R., Roitsch, C. & Fenton, J. W. d. (1990). The structure of a complex recombinant hirudin and human alpha-thrombin. Science, 249(4966), 277-280.
20. Schechter, I. & Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 159.
21. Seong, I. S., Lee, H. R., Seol, J. H., Park, S. K., Lee, C. S., Suh, S. W., Hong, Y. M., Kang, M. S., Ha, D. B. & Chung, C. H. (1994). The P1 reactive site methionine residue of ecotin is not crucial for its specificity on target proteases. A potent inhibitor of pancreatic serine proteases from Escherichia coli. J. Biol. Chem. 269(34), 21915-21918.
22. Seymour, J. L., Lindquist, R. N., Dennis, M. S., Moffat, B., Yansura, D., Reilly, D., Wessinger, M. E. & Lazarus, R. A. (1994). Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa. Biochemistry, 33(13), 3949-3958.
23. Takeuchi, Y., Satow, T., Nakamura, K. T. & Mitsui, Y. (1991). Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 Å resolution. J. Mol. Biol. 221(1), 309-325.
24. van de Locht, A., Lamba, D., Bauer, M., Huber, R., Friedrich, T., Kroger, B., Hoffken, W. & Bode, W. (1995). Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J. 14(21), 5149-5157.
25. van de Locht, A., Stubbs, M. T., Bode, W., Friedrich, T., Bollschweiler, C., Hoffken, W. & Huber, R. (1996). The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J. 15(22), 6011-6017.
26. Wang, C. I., Yang, Q. & Craik, C. S. (1995). Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin. J. Biol. Chem. 270(20), 12250-12256.
27. Wells, J. A. (1990). Additivity of mutational effects in proteins. Biochemistry, 29(37), 8509-8517.
28. Wells, J. A. (1996). Binding in the growth hormone receptor complex. Proc. Natl Acad. Sci USA, 93(1), 1-6.
29. Wells, J. A., Cunningham, B. C., Graycar, T. P. & Estell, D. A. (1987). Recruitment of substrate-specificity properties from one enzyme into a related one by protein engineering. Proc. Natl Acad. Sci. USA, 84(15), 5167-5171.
30. Yang, S. Q. & Craik, C. S. (1998). Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator. J. Mol. Biol. 279, 1001-1011.